NCT06044974View on ClinicalTrials.gov

Nd-YAG Laser Versus Epidermal Growth Factor For Myogenic Tempromandibular Disorder.

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

January 21, 2023

Primary Completion Date

August 10, 2023

Study Completion Date

January 10, 2024

Conditions
Temporomandibular Joint Disorders
Interventions
DEVICE

Nd-YAG Fotona

four combined therapy sessions using 1064 nm Nd-YAG laser (once/week)

DRUG

Epidermal Growth Factor

"Epidermal growth factor EGF-genesis by Dermaquel Paris n into masseter and temporalis muscles. Each muscle will be divided into 3 zones; origin, body and insertion for masseter muscle, anterior, middle, and posterior for temporalis muscle"

Trial Locations (1)

Unknown

Alexandria University, Alexandria

All Listed Sponsors
lead

Alexandria University

OTHER